Back to Search Start Over

De novo putative loss‐of‐function variants in TAF4 are associated with a neuro‐developmental disorder.

Authors :
Janssen, Beau D. E.
van den Boogaard, Marie‐Jose H.
Lichtenbelt, Klaske
Seaby, Eleanor G.
Stals, Karen
Ellard, Sian
Newbury‐Ecob, Ruth
Dixit, Abhijit
Roht, Laura
Pajusalu, Sander
Õunap, Katrin
Firth, Helen V.
Buckley, Michael
Wilson, Meredith
Roscioli, Tony
Tidwell, Timothy
Mao, Rong
Ennis, Sarah
Holwerda, Sjoerd J.
van Gassen, Koen
Source :
Human Mutation; Dec2022, Vol. 43 Issue 12, p1844-1851, 8p
Publication Year :
2022

Abstract

TATA‐binding protein associated factor 4 (TAF4) is a subunit of the Transcription Factor IID (TFIID) complex, a central player in transcription initiation. Other members of this multimeric complex have been implicated previously as monogenic disease genes in human developmental disorders. TAF4 has not been described to date as a monogenic disease gene. We here present a cohort of eight individuals, each carrying de novo putative loss‐of‐function (pLoF) variants in TAF4 and expressing phenotypes consistent with a neuro‐developmental disorder (NDD). Common features include intellectual disability, abnormal behavior, and facial dysmorphisms. We propose TAF4 as a novel dominant disease gene for NDD, and coin this novel disorder "TAF4‐related NDD" (T4NDD). We place T4NDD in the context of other disorders related to TFIID subunits, revealing shared features of T4NDD with other TAF‐opathies. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10597794
Volume :
43
Issue :
12
Database :
Complementary Index
Journal :
Human Mutation
Publication Type :
Academic Journal
Accession number :
160765930
Full Text :
https://doi.org/10.1002/humu.24444